Therefore, taking into account also the heterogeneity of the disease and that almost 10% of PCa is PSMA negative, we believe that choline PET/CT still represents an effective molecular imaging technique that should be considered (16). This evidence concerns the gene FOLH1 and posterior cortical atrophy.